Immune
The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium
Heilborn JD, Nilsson MF, Kratz G, et al. · J Invest Dermatol · 2003
PMID: 12603850 · DOI: 10.1046/j.1523-1747.2003.12120.x
Summary
Human acute vs chronic skin-wound study characterizing LL-37 expression in re-epithelializing epidermis. Endpoints: immunohistochemistry, in vitro keratinocyte migration with LL-37 blockade.
Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.
Compounds referenced in this study
- View product →LL-3737-residue human cathelicidin antimicrobial peptide studied in innate-immunity and wound-healing research.
Guides covering this compound
More Immune citations
- The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trialCrit Care · 2013
- The efficacy and safety of thymosin alpha-1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trialBMJ · 2025
- Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trialLiver · 1996